G7 SYNERGON is an integrated Biopharmaceutical service provider, offering drug discovery research, clinical and consulting solutions, established in 2008.

We offer services to the Global Pharmaceutical, Healthcare and Biotech industry.

We believe that people work primarily towards an opportunity to contribute to society, which is the main driving and motivating force for any fast growing company. We provide equal opportunities to our team, without bias and within a completely transparent and ethical environment.

Our Research vertical provides services which adequately meet client requirements in the spheres of development of novel small molecules (Target identification, validation and Lead optimization) and isolated bioactive compounds for various therapeutic areas like Tuberculosis, Antifungal, Antiviral, Oncology, Metabolic disorders, Alzheimer’s disease, pain and inflammation, etc.

Our Business consulting division provides services in Epidemiology, Forecasting, Competitive Intelligence, Oncology, Sales Force Effectiveness, Key Opinion Leaders Practice and Market Research.

G7 SYNERGON’s strong Clinical Trial Management conducts phase trials, ensuring safety of patients and generates high quality data and reports.

It is our earnest endeavor to utilize our keen market insight to generate comprehensive business optimization solutions to our global customers. It is with this motto that we at G7 SYNERGON, aspire to surge ahead in the fields of Life Science, Clinical research and Consulting with zeal and passion.

RECOGNITIONS

“G7 SYNERGON has been recognized by the Department of Scientific and Industrial Research (DSIR)”